Intas Pharmaceuticals Limited Mitomycin Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Mitomycin Export Records India — #1 Exporter, 46 Shipments, $2.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Mitomycin

India Pharmaceutical Trade Intelligence

$8.2M213 Suppliers103 CountriesHS 30049049

ExportsIndia → UNITED STATES63.5%India → ALGERIA7.5%

ImportsUNITED STATES → India$69.3K UNITED KINGDOM → India$7.0K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: RX CROSSROADS

Intas Pharmaceuticals Limited — Mitomycin Exporter #1 | $2.3M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Mitomycin Exporter Profile

Indian Pharmaceutical Exporter · #1 for Mitomycin · $2.3M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #1 Indian exporter of Mitomycin with $2.3M in export value and 46 verified shipments. Intas Pharmaceuticals Limited holds a 28.2% market share in Mitomycin exports across 6 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Mitomycin Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Mitomycin export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Mitomycin?

Country	Value	Shipments	Share
UNITED STATES	$1.0M	34	70.4%
JAPAN	$204.6K	6	14.3%
UNITED KINGDOM	$50.0K	1	3.5%
CANADA	$50.0K	1	3.5%

Who Are the Top Buyers of Mitomycin from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$290.9K	15
TO THE ORDER	UNITED STATES	$200.0K	4
B BRAUN MEDICAL INC	UNITED STATES	$150.0K	3
FOUNDATION CARE	UNITED STATES	$150.0K	3
KYOWA KIRIN CO LTD	JAPAN	$120.0K	3
FOUNDATION CARE.	UNITED STATES	$118.4K	3
XXOWAXXIRIXXCO XXLIMITEDX	JAPAN	$67.3K	2
XXCORXXHEAXXHCAXX LTXX	UNITED KINGDOM	$51.2K	2
ACCORD HEALTHCARE INC	CANADA	$50.0K	1
ACCORD HEALTHCARE POLSKA SP Z O O	POLAND	$50.0K	1

Intas Pharmaceuticals Limited supplies Mitomycin to 19 buyers globally. The largest buyer is EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES), followed by TO THE ORDER (UNITED STATES) and B BRAUN MEDICAL INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Mitomycin Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHAR.DRUGS AND MED: MITOSOL 0.2MG/VIAL EYEDROP (MOBI-USA Mitomycin for Solution0.2MG EACH VIAL CONTAINS : MITOMYICIN US	$200.0K	4
PH.DRU.& MED.: MITOSOL 0.2MG/VIAL EYE DROP (MITOMYCIN FOR OPHTHALMIC SOLUTION 0.2MG/VIAL EACH VIAL CONT. MITOMYCIN USP 0	$168.4K	4
PH.DRU.& MED.: MITOSOL 0.2MG/VIAL EYE DROP MITOMYCIN FOR OPHTHALMIC SOLUTION 0.2MG/VIAL EACH VIAL CONT. MITOMYCIN USP 0	$150.0K	3
PHR DRUGS&MEDI MITOMYCIN FOR INJ USP 5MG	$124.8K	6
PHA.DRU & MEDI, MITOSOL 0.2MG/VIALEYEDROP (MOBI-USA Mitomycin for Solution 0.2MG EACH VIAL CONTAINS : MITOMY	$100.0K	2
PHARMA DRUGS & MEDI MITOMYCIN FOR INJ US	$96.9K	5
MITOMYCIN POWD FOR SOL 2MG/VIALKKC-JP	$87.3K	3
MITOMYCIN POWD FOR SOL 2MG/VIAL(KKC-JP)	$67.3K	2
MITOMYCIN POWDER 10MG/VIAL 1V	$51.2K	2
MITOMYCIN 20MG/V 1X1V ACC-CAN	$50.0K	1

Intas Pharmaceuticals Limited exports 30 distinct Mitomycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHAR.DRUGS AND MED: MITOSOL 0.2MG/VIAL EYEDROP (MOBI-USA Mit with 4 shipments worth $200.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Mitomycin Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED ★	$2.3M	46	6	$50.0K
2	MYLAN LABORATORIES LIMITED	$1.3M	25	1	$50.0K
3	NAPROD LIFE SCIENCES PRIVATE LIMITED	$738.6K	19	3	$38.9K

Intas Pharmaceuticals Limited ranks #1 among 213 Indian Mitomycin exporters. Average shipment value of $50.0K compared to the market average of $26.4K. The closest competitors by value are MYLAN LABORATORIES LIMITED and NAPROD LIFE SCIENCES PRIVATE LIMITED.

Which Indian Ports Ship Mitomycin Exports?

Port	Shipments	% Share
SAHAR AIR	341	25.6%
SAHAR AIR CARGO ACC (INBOM4)	261	19.6%
Bombay Air	104	7.8%
DELHI AIR	91	6.8%
DELHI AIR CARGO ACC (INDEL4)	72	5.4%
AHEMDABAD AIR ACC (INAMD4)	62	4.7%
AHEMDABAD AIR	55	4.1%
Bombay Air Cargo	43	3.2%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Mitomycin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Mitomycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 53 individual customs records matching Intas Pharmaceuticals Limited exporting Mitomycin, covering 30 formulations to 10 countries via 19 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 103+ countries, 456+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Mitomycin

Mitomycin

Intas Pharmaceuticals Limited — Mitomycin Exporter Profile

Intas Pharmaceuticals Limited — Mitomycin Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Mitomycin?

Who Are the Top Buyers of Mitomycin from Intas Pharmaceuticals Limited?

What Is India's Total Mitomycin Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Mitomycin Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Mitomycin Exporters?

What Mitomycin Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Mitomycin to Key Markets

United States — FDA

Japan — PMDA

United Kingdom — MHRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Mitomycin Exporters?

Which Indian Ports Ship Mitomycin Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Mitomycin Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Mitomycin Export Data from Intas Pharmaceuticals Limited

Mitomycin Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source